264 results Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector. Stibbe advises Aedifica Stibbe advised Aedifica on the acquisition of a healthcare residence for the elderly in Franeker (Friesland). Stibbe advises Agendia Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management. Stibbe advises Canon Medical Systems Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon. Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist). Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group. Stibbe advises on the equity offering of ProQR Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). Stibbe advises Lundbeck Stibbe advised Lundbeck on the acquisition of Prexton Therapeutics BV for an amount of up to EUR 905 million. Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe. Stibbe advises Aedifica Stibbe's Real Estate Transaction Group advised Aedifica NV, a Belgian listed company investing in healthcare real estate, on the further expansion of its portfolio in the Netherlands. Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations. Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels. Mini-symposium “De accountant – Paard van Troje?” Op dinsdag 21 mei organiseert de afdeling Corporate Criminal Law & Investigations van Stibbe een mini-symposium rond het thema van de accountant als pseudo-opsporingsambtenaar en de controlecliënt als potentiële verdachte. Stibbe advises worldwide seeds leader Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors. Belgian data protection authority fines hospital after data breach for taking insufficient data protection measures In 2021, a Belgian hospital fell victim to a ransomware attack that disrupted critical operations and compromised the personal data of 300,000 people. As a result, the Belgian data protection authority imposed a fine of €200,000 three years later. New EDPB statement on implementation of PNR directive: impact and recommendations The European Data Protection Board (EDPB) approved a new statement regarding the application of the PNR directive, in light of the ruling of the Court of Justice of the EU (CJEU) in case C-817/19. Key takeaways and insights from the EDPB Pseudonymisation Guidelines On 16 January, 2025, the EDPB released its guidelines on pseudonymisation. These guidelines are not yet finalized, as they remain open for public consultation until 28 February. In this blogpost, we highlight the key takeaways. Is the Metaverse really dead? Well, not according to the EU Commission… The European Commission recently unveiled its vision for the Metaverse and virtual worlds. Pagination Previous page Page 6 Current page 7 Page 8 Page 9 Next page
Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.
Stibbe advises Aedifica Stibbe advised Aedifica on the acquisition of a healthcare residence for the elderly in Franeker (Friesland).
Stibbe advises Agendia Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management.
Stibbe advises Canon Medical Systems Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon.
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist).
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group.
Stibbe advises on the equity offering of ProQR Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR").
Stibbe advises Lundbeck Stibbe advised Lundbeck on the acquisition of Prexton Therapeutics BV for an amount of up to EUR 905 million.
Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.
Stibbe advises Aedifica Stibbe's Real Estate Transaction Group advised Aedifica NV, a Belgian listed company investing in healthcare real estate, on the further expansion of its portfolio in the Netherlands.
Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations.
Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.
Mini-symposium “De accountant – Paard van Troje?” Op dinsdag 21 mei organiseert de afdeling Corporate Criminal Law & Investigations van Stibbe een mini-symposium rond het thema van de accountant als pseudo-opsporingsambtenaar en de controlecliënt als potentiële verdachte.
Stibbe advises worldwide seeds leader Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors.
Belgian data protection authority fines hospital after data breach for taking insufficient data protection measures In 2021, a Belgian hospital fell victim to a ransomware attack that disrupted critical operations and compromised the personal data of 300,000 people. As a result, the Belgian data protection authority imposed a fine of €200,000 three years later.
New EDPB statement on implementation of PNR directive: impact and recommendations The European Data Protection Board (EDPB) approved a new statement regarding the application of the PNR directive, in light of the ruling of the Court of Justice of the EU (CJEU) in case C-817/19.
Key takeaways and insights from the EDPB Pseudonymisation Guidelines On 16 January, 2025, the EDPB released its guidelines on pseudonymisation. These guidelines are not yet finalized, as they remain open for public consultation until 28 February. In this blogpost, we highlight the key takeaways.
Is the Metaverse really dead? Well, not according to the EU Commission… The European Commission recently unveiled its vision for the Metaverse and virtual worlds.